WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates
Houston, Texas--(Newsfile Corp. - June 15, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) continues to attract attention within the biotechnology sector as the Company advances its neuro-oncology pipeline and strengthens its balance sheet ahead of anticipated clinical development milestones. NeOnc's new Securities Purchase Agreement with accredited investors provides for up to $5 million through the issuance of Series A Convertible Preferred Stock. The financing arrives as NeOnc continues...
2026-06-15 8:35 AM EDT
The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade
Houston, Texas--(Newsfile Corp. - June 9, 2026) - For years, artificial intelligence has dominated conversations surrounding the future of healthcare innovation. Yet beyond the AI-driven headlines, another potentially groundbreaking revolution is unfolding in one of medicine's most challenging arenas: the fight against brain cancer. As researchers pursue new approaches to treat aggressive and often treatment-resistant tumors, emerging innovators such as NeOnc Technologies Holdings (NASDAQ:...
2026-06-09 8:45 AM EDT